MedMira Inc. Announces to Launch VYRA™ CoV2Flu Rapid Antigen Rapid Test
Summary – Launch of VYRA™ CoV2Flu Rapid Antigen Rapid Test (VYRA™ CoV2Flu). Based on MedMira’s proprietary technology, this 3-in-1 test is developed…
Summary – Launch of VYRA™ CoV2Flu Rapid Antigen Rapid Test (VYRA™ CoV2Flu). Based on MedMira’s proprietary technology, this 3-in-1 test is developed…
Synopsis: Alembic Pharma share price fell over 4 percent in intraday trade on December 16 following reports that the US Food and…
Synopsis: The EMA’s human medicines committee has said it cannot approve Biogen and Eisai’s Alzheimer’s disease therapy Aduhelm, saying it was unconvinced…
Summary : Morepen Laboratories Limited has received USFDA approval for its anti-allergy drug fexofinadine hydrochloride Fexofinadine is most widely used, second generation…
Synopsis- Ichnos Sciences, Glenmark’s drug discovery subsidiary based in the US, on Tuesday said it has entered into an exclusive agreement with…
Summary – The U.S. drugmaker will pay $100 a share in an all-cash transaction for San Diego-based Arena, bringing assets in gastroenterology,…
Summary : Alembic said it has so far received 15 product approvals this year. Alembic Pharma received approval from the US health…
Abeprazan (DWP14012) is a potassium-competitive acid blocker. Abeprazan inhibits H+, K+– ATPase by reversible potassium-competitive ionic binding with no acid activation required. Abeprazan is…
HIGHLIGHTS: Spain’s top research institution struck a licensing deal that paves the way for its COVID-19 antibody test to be produced more…
Synopsis: BioMarin Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval to VOXZOGO™ (Vosoritide) for Injection, indicated…